Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin (Q44798515)

From Wikidata
Jump to navigation Jump to search
scientific article published in March 2004
edit
Language Label Description Also known as
English
Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin
scientific article published in March 2004

    Statements

    Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin (English)
    Jae-Hyun Kim
    Su-Kyung Lee
    Min-Hyo Ki
    Won-Kyu Choi
    Soon-Kil Ahn
    Hee-Jong Shin
    Chung Il Hong
    1 March 2004

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit